Concentration-time Profiles
Concentration-time Profiles - Related Videos
01:15
Drug Concentration Versus Time Correlation
0 Views •
2024
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation. Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
02:39
The Integrated Rate Law: The Dependence of Concentration on Time
0 Views •
2020
While the differential rate law relates the rate and concentrations of reactants, a second form of rate law called the integrated rate law relates concentrations of reactants and time. Integrated rate laws can be used to determine the amount of reactant or product present after a period of time or to estimate the time required for a reaction to proceed to a certain extent. For example, an integrated rate law helps determine the length of time a radioactive material must be stored for its...
14:11
Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis
0 Views •
Cited by 21 •
2016
We illustrate the application of 1H(15N,αγ)12C resonant nuclear reaction analysis (NRA) to quantitatively evaluate the density of hydrogen atoms on the surface, in the volume, and at an interfacial layer of solid materials. The near-surface hydrogen depth profiling of a Pd(110) single crystal and of SiO2/Si(100) stacks is described.
10:27
Determining Genetic Expression Profiles in C. elegans Using Microarray and Real-time PCR
0 Views •
Cited by 12 •
2011
Microarray analysis was conducted to determine genetic expression profiles in C. elegans, and real-time PCR was used to validate and quantify microarray data.
09:26
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
0 Views •
Cited by 10 •
2014
We describe a protocol of real time PCR to profile microRNAs in the cerebrospinal fluid (CSF). With the exception of RNA extraction protocols, the procedure can be extended to RNA extracted from other body fluids, cultured cells, or tissue specimens.
FAQs
Each pharmacokinetic process contributes to a different part of the curve. Absorption influences the initial rise after administration, distribution affects how the substance moves through biological compartments, and metabolism and excretion contribute to the later decline. Considering these processes together helps researchers interpret whether changes in the profile reflect drug handling rather than concentration alone.
Peak concentration indicates the highest measured exposure reached after administration, while time to peak identifies when that maximum occurs. Together, these measures describe the timing and magnitude of the drug’s greatest concentration. Their values can help researchers compare treatments and evaluate whether a dosing approach produces exposure consistent with intended therapeutic or safety goals.
The elimination rate describes how quickly concentration decreases during the later portion of the profile, whereas the area under the curve summarizes exposure across time. Examining both provides complementary information: one addresses the pace of removal, and the other reflects overall exposure. These measures support pharmacokinetic interpretation, formulation comparisons, and decisions about appropriate dosing intervals.
Profiles allow researchers to compare how formulations affect exposure and the timing of concentration changes. Differences in peak concentration, time to peak, elimination behavior, or area under the curve may indicate that formulations produce different pharmacokinetic patterns. Such comparisons can support evaluations of bioavailability, meaning the extent to which a formulation contributes to measured systemic exposure.
Researchers examine the exposure pattern produced by a formulation and compare relevant profile measures, particularly the area under the curve and concentration-related features. This approach helps determine whether one formulation provides a different extent or timing of exposure than another. The resulting comparison can inform formulation development and clinical evaluation without relying on a single concentration measurement.
A profile connects administered treatment with measured exposure over time, allowing researchers to consider peak concentration, total exposure, and elimination behavior together. These findings can guide selection of a dose and dosing interval that align with desired therapeutic exposure. The same analysis also helps identify patterns that could indicate insufficient exposure or a risk of toxic exposure.
Interpreting the curve helps place observed drug concentrations in relation to therapeutic and toxic exposure. Concentration patterns can therefore be evaluated alongside whether the treatment is expected to produce benefit or raise safety concerns. In clinical research, this relationship supports assessment of treatment performance and helps explain why exposure timing and magnitude matter beyond the administered dose.